Shopping Cart
- Remove All
Your shopping cart is currently empty
CLEFMA has anti-proliferative activity. CLEFMA inhibits tumor growth associated with NF-κB-regulated anti-inflammatory and anti-metastatic effects.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $62 | In Stock | |
| 5 mg | $141 | In Stock | |
| 10 mg | $209 | In Stock | |
| 25 mg | $333 | In Stock | |
| 50 mg | $475 | In Stock | |
| 100 mg | $638 | In Stock | |
| 200 mg | $833 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $161 | In Stock |
| Description | CLEFMA has anti-proliferative activity. CLEFMA inhibits tumor growth associated with NF-κB-regulated anti-inflammatory and anti-metastatic effects. |
| Targets&IC50 | A549 cells:8.9 μM, H441 cells:6.4 μM |
| In vitro | CLEFMA induces autophagic death in H441 cells[1]. CLEFMA inhibits the viability of H441 and A549 cells, with IC50s of 6.4 and 8.9 μM, respectively[2]. CLEFMA induces apoptosis and reduces the DNA-binding activity of NF-κB in H441 cells in a dose-dependent manner[2]. |
| In vivo | Daily intraperitoneal injection of 0.2-0.4 mg/kg CLEFMA for 4 weeks, CLEFMA inhibits tumor growth and FDG uptake in tumor tissue in a xenograft mouse model [2]. In addition, CLEFMA downregulates the expression of anti-apoptotic markers cIAP1, Bcl-xL, Bcl-2, and survivin, and induces the cleavage and expression of the pro-apoptotic protein BID [2]. |
| Molecular Weight | 442.29 |
| Formula | C23H17Cl2NO4 |
| Cas No. | 1246964-32-8 |
| Smiles | C(=C\1/C(=O)\C(=C\C2=C(Cl)C=CC=C2)\CN(C(/C=C\C(O)=O)=O)C1)\C3=C(Cl)C=CC=C3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 60 mg/mL (135.66 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.